Paper20534591
Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs.
Kim Y and 8 others. J Biol Chem, 2010. Cited by 55 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. Papers, record 20534591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20534591
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DEAD-box RNA Helicases | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Histone Deacetylase 2 | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Antineoplastic Agents | |
| Cell Line, Tumor | |
| Humans | |
| Neoplasm Proteins | |
| Snail Family Transcription Factors | |
| Transcription Factors | |
| Transcriptional Activation |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19088198 | Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/19088198 | PubMed |
| 2 | 19147576 | Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. | Cancer Res | 2009 | https://conductscience.org/library/papers/19147576 | PubMed |
| 3 | 17616692 | Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide. | Cancer Res | 2007 | https://conductscience.org/library/papers/17616692 | PubMed |
| 4 | 16651429 | Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. | Cancer Res | 2006 | https://conductscience.org/library/papers/16651429 | PubMed |
| 5 | 11922625 | Identification and characterization of a novel cancer/testis antigen gene CAGE. | Biochem Biophys Res Commun | 2002 | https://conductscience.org/library/papers/11922625 | PubMed |
| 6 | 18359760 | Notch-1 regulates transcription of the epidermal growth factor receptor through p53. | Carcinogenesis | 2008 | https://conductscience.org/library/papers/18359760 | PubMed |
| 7 | 15509580 | Celastrols as inducers of the heat shock response and cytoprotection. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15509580 | PubMed |
| 8 | 18391986 | Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes. | Oncogene | 2008 | https://conductscience.org/library/papers/18391986 | PubMed |
| 9 | 18317451 | Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53. | Oncogene | 2008 | https://conductscience.org/library/papers/18317451 | PubMed |
| 10 | 18343027 | Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression. | Cancer Lett | 2008 | https://conductscience.org/library/papers/18343027 | PubMed |
| 11 | 19544473 | Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. | Stem Cells | 2009 | https://conductscience.org/library/papers/19544473 | PubMed |
| 12 | 19447865 | Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19447865 | PubMed |
| 13 | 17110449 | Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. | Blood | 2007 | https://conductscience.org/library/papers/17110449 | PubMed |
| 14 | 19449375 | Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2. | Int J Cancer | 2009 | https://conductscience.org/library/papers/19449375 | PubMed |
| 15 | 19254279 | Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells. | Br J Pharmacol | 2009 | https://conductscience.org/library/papers/19254279 | PubMed |
| 16 | 18794809 | Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. | Oncogene | 2008 | https://conductscience.org/library/papers/18794809 | PubMed |
| 17 | 19362090 | E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19362090 | PubMed |
| 18 | 18604200 | EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. | Nat Cell Biol | 2008 | https://conductscience.org/library/papers/18604200 | PubMed |
| 19 | 14673164 | Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/14673164 | PubMed |
| 20 | 20160026 | Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway. | Cancer Res | 2010 | https://conductscience.org/library/papers/20160026 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42239378 | The RNA helicase DDX53 (CAGE) contributes to RNA metabolism in a human germ cell model. | bioRxiv | 2026 | https://conductscience.org/library/papers/42239378 | PubMed |
| 41755778 | Exploratory Proteomic Profiling Reveals Potential Mediators of 5-FU Response under p53 Deficiency in Colon Cancer Cells. | Biomol Ther (Seoul) | 2026 | https://conductscience.org/library/papers/41755778 | PubMed |
| 39935431 | Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/39935431 | PubMed |
| 39136024 | Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens. | Front Immunol | 2024 | https://conductscience.org/library/papers/39136024 | PubMed |
| 38920983 | HDAC9 and miR-512 Regulate CAGE-Promoted Anti-Cancer Drug Resistance and Cellular Proliferation. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/38920983 | PubMed |
| 37834126 | Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834126 | PubMed |
| 37763070 | miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53. | J Pers Med | 2023 | https://conductscience.org/library/papers/37763070 | PubMed |
| 36980267 | Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. | Cells | 2023 | https://conductscience.org/library/papers/36980267 | PubMed |
| 36968022 | HDAC2 as a target for developing anti-cancer drugs. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/36968022 | PubMed |
| 36834846 | The Potential of Senescence as a Target for Developing Anticancer Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834846 | PubMed |
| 35769258 | DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35769258 | PubMed |
| 35682560 | Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682560 | PubMed |
| 34830845 | Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34830845 | PubMed |
| 34298641 | MOUSSE: Multi-Omics Using Subject-Specific SignaturEs. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298641 | PubMed |
| 34113619 | The CAGE-MiR-181b-5p-S1PR1 Axis Regulates Anticancer Drug Resistance and Autophagy in Gastric Cancer Cells. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34113619 | PubMed |
| 32626712 | Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32626712 | PubMed |
| 31875024 | MicroRNA-548 regulates high mobility group box 1 expression in patients with preterm birth and chorioamnionitis. | Sci Rep | 2019 | https://conductscience.org/library/papers/31875024 | PubMed |
| 31799196 | CAGE-miR-140-5p-Wnt1 Axis Regulates Autophagic Flux, Tumorigenic Potential of Mouse Colon Cancer Cells and Cellular Interactions Mediated by Exosomes. | Front Oncol | 2019 | https://conductscience.org/library/papers/31799196 | PubMed |
| 31772231 | Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network. | Nat Commun | 2019 | https://conductscience.org/library/papers/31772231 | PubMed |
| 30619741 | CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells. | Front Oncol | 2018 | https://conductscience.org/library/papers/30619741 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DDX53 | 168400 | PubTator's text mining | https://conductscience.org/library/genes/168400 | NCBI Gene |
| DNMT1 | 1786 | PubTator's text mining | https://conductscience.org/library/genes/1786 | NCBI Gene |
| HDAC2 | 3066 | PubTator's text mining | https://conductscience.org/library/genes/3066 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20534591
GET https://conductscience.org/api/papers/v1/20534591/references?page=2